BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Diagnosis
32 results:

  • 1. Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
    Riis T; Bonnema SJ; Brix TH; Folkestad L
    Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38367342
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Facilitation of Definitive cancer diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With thyroid Nodules.
    Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
    JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Integration of Artificial Intelligence Decision Aids to Reduce Workload and Enhance Efficiency in thyroid Nodule Management.
    Tong WJ; Wu SH; Cheng MQ; Huang H; Liang JY; Li CQ; Guo HL; He DN; Liu YH; Xiao H; Hu HT; Ruan SM; Li MD; Lu MD; Wang W
    JAMA Netw Open; 2023 May; 6(5):e2313674. PubMed ID: 37191957
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The diagnostic efficacy and inappropriate biopsy rate of ACR TI-RADS and ATA guidelines for thyroid nodules in children and adolescents.
    Li G; Zhang B; Liu J; Xiong Y
    Front Endocrinol (Lausanne); 2023; 14():1052945. PubMed ID: 37051202
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer.
    Kim KJ; Kim KJ; Choi J; Kim NH; Kim SG
    J Natl Cancer Inst; 2023 Jun; 115(6):695-702. PubMed ID: 36821433
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of Delayed Surgery and Clinical Outcomes in Intermediate- and High-risk Papillary thyroid cancer.
    Zhou H; Wu J; Shi L; Wang Y; Liu B
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3389-3397. PubMed ID: 36056633
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study.
    Wang Y; Qiao L; Yang J; Li X; Duan Y; Liu J; Chen S; Li H; Liu D; Fang T; Ma J; Li X; Ye F; Wan J; Wei J; Xu Q; Guo E; Jin P; Wu M; Zhang L; Xia Y; Wu Y; Shao J; Feng Y; Zhang Q; Yang Z; Chen G; Zhang Q; Li X; Wang S; Hu J; Wang X; Tan MP; Takabe K; Kong B; Yang Q; Ma D; Gao Q
    Cancer Commun (Lond); 2021 Dec; 41(12):1373-1386. PubMed ID: 34738326
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma.
    Aldrich KD; Horne VE; Bielamowicz K; Sonabend RY; Scheurer ME; Paulino AC; Mahajan A; Chintagumpala M; Okcu MF; Brown AL
    J Neurooncol; 2021 Oct; 155(1):93-100. PubMed ID: 34596831
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer.
    Gunel NS; Birden N; Kurt CC; Bagca BG; Shademan B; Sogutlu F; Ozates NP; Avci CB
    Mol Biol Rep; 2021 Aug; 48(8):6085-6091. PubMed ID: 34374891
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Role of Claudin-1 on diagnostic cut-off value and multiple tests in patients with papillary thyroid carcinoma].
    Hou WD; Ding HX; Li HM; Wang JH; Liu YF
    Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2233-2237. PubMed ID: 34333937
    [No Abstract]    [Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 2B: Frequency of physical stigmata-Results of the GPOH-MET registry.
    Redlich A; Lessel L; Petrou A; Mier P; Vorwerk P
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28056. PubMed ID: 31724322
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Spindle cell oncocytoma of the pituitary gland.
    Giantini Larsen AM; Cote DJ; Zaidi HA; Bi WL; Schmitt PJ; Iorgulescu JB; Miller MB; Smith TR; Lopes MB; Jane JA; Laws ER
    J Neurosurg; 2018 Oct; 131(2):517-525. PubMed ID: 30485213
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Intermediate-Risk Papillary thyroid cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
    Llamas-Olier AE; Cuéllar DI; Buitrago G
    Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
    Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
    J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical Prognostic Score for Predicting Disease Remission with Differentiated thyroid cancers.
    Somboonporn C; Mangklabruks A; Thakkinstian A; Vatanasapt P; Nakaphun S
    Asian Pac J Cancer Prev; 2016; 17(6):2805-10. PubMed ID: 27356694
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY thyroid cancer PATIENTS.
    Yang SP; Bach AM; Tuttle RM; Fish SA
    Endocr Pract; 2015 Dec; 21(12):1372-9. PubMed ID: 26372300
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Management of cystic or predominantly cystic thyroid nodules: role of simple aspiration of internal fluid.
    Choi WJ; Baek JH; Choi YJ; Lee JH; Ha EJ; Lee WC; Lim HK; Kim WB
    Endocr Res; 2015; 40(4):215-9. PubMed ID: 25839339
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pathology of thyroglossal duct: an institutional experience.
    Wei S; LiVolsi VA; Baloch ZW
    Endocr Pathol; 2015 Mar; 26(1):75-9. PubMed ID: 25577275
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. TSH measurement is not an appropriate screening test for autonomous functioning thyroid nodules: a retrospective study of 368 patients.
    Chami R; Moreno-Reyes R; Corvilain B
    Eur J Endocrinol; 2014 Apr; 170(4):593-9. PubMed ID: 24451082
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
    Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN
    Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.